ANTI-XA MONITORING OF THERAPEUTIC ENOXAPARIN IN PATIENTS WEIGHING AT LEAST 90 KILOGRAMS

被引：0
|
作者：
Hur, Mina [1 ]
Kim, Hanah [1 ]
Park, Mikyoung [1 ]
Chung, Hee-Jung [2 ]
机构：
[1] Konkuk Univ, Sch Med, Dept Lab Med, Seoul, South Korea
[2] Natl Canc Ctr Hosp, Dept Lab Med, Goyang, South Korea
来源：
AMERICAN JOURNAL OF HEMATOLOGY | 2018年 / 93卷 / 09期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：E26 / E27
页数：2
相关论文
共 50 条
  • [21] Enoxaparin titrated by anti-Xa levels reduces venous thromboembolism in trauma patients
    Gates, Rebecca S.
    Lollar, Daniel, I
    Collier, Bryan R.
    Smith, Jacob
    Faulks, Emily R.
    Gillen, Jacob R.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2022, 92 (01): : 93 - 97
  • [22] Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity
    van Oosterom, Nameer
    Winckel, Karl
    Barras, Michael
    [J]. JOURNAL OF THROMBOSIS AND THROMBOLYSIS, 2019, 48 (03) : 387 - 393
  • [23] Evaluation of weight based enoxaparin dosing on anti-Xa concentrations in patients with obesity
    Nameer van Oosterom
    Karl Winckel
    Michael Barras
    [J]. Journal of Thrombosis and Thrombolysis, 2019, 48 : 387 - 393
  • [24] Factors influencing enoxaparin anti-Xa activity in surgical critically ill patients
    Vincent, Philippe D.
    Albert, Martin
    Champagne, Marie-Christine
    Zikos, Theodora
    Boulanger, Isabelle
    Blais, Lucie
    Williamson, David R.
    [J]. JOURNAL OF CRITICAL CARE, 2011, 26 (04) : 347 - 351
  • [25] IMPACT OF CLOPIDOGREL ON SERUM ANTI-XA LEVELS IN PATIENTS RECEIVING ENOXAPARIN TREATMENT
    Yang, Solomon C.
    Wong, Shing Chiu
    Hwang, Juey-Jen
    [J]. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2010, 55 (10)
  • [26] Evaluation of assay performance monitoring Xa inhibitors with technochrom anti-Xa (AT plus ) and technochrom Anti-Xa
    Wagner, L.
    Geiter, S.
    Stranz, S.
    Kaufmann, V
    Mager, J.
    Graf, M.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 : 123 - 124
  • [27] Prolonged anti-Xa activity due to enoxaparin at the end of pregnancy
    Ortigueira, M.
    Capanna, F.
    Boehlen, F.
    de Tejada, B. Martinez
    Savoldelli, G.
    [J]. ANAESTHESIA AND INTENSIVE CARE, 2014, 42 (05) : 668 - 670
  • [28] Predictive modeling of anti-Xa activity with enoxaparin use in pregnancy
    Patil, Avinash
    Grotegut, Chad
    Dotters-Katz, Sarah
    Swamy, Geeta
    Murtha, Amy
    James, Andra
    [J]. AMERICAN JOURNAL OF OBSTETRICS AND GYNECOLOGY, 2013, 208 (01) : S83 - S83
  • [29] Variability of plasma anti-Xa activities with different lots of enoxaparin
    Gosselin, RC
    King, JH
    Janatpour, KA
    Dager, WE
    Larkin, EC
    Owings, JT
    [J]. ANNALS OF PHARMACOTHERAPY, 2004, 38 (04) : 563 - 568
  • [30] Validation of a linear dosing nomogram for enoxaparin anti-Xa levels
    Currie, Janna L.
    Huggins, Jenna M.
    Allender, J. Erin
    Barakat, Oksana
    [J]. PHARMACOTHERAPY, 2012, 32 (10): : E282 - E282
12345